Author Details
MRP ₹161
(Inclusive of all Taxes)
₹21.7 Cashback (14%)
coupon
Available Offers
APLICICISave 19% on medicine orders above Rs. 1999 with ICICI credit Card
ONECARD5Flat 5% off on non- medicine orders above Rs. 700 with OneCard
ONECARD18Flat 18% Off on medicine orders above Rs. 1250 with OneCard
APOLLOMOBIKWIKUpto Rs. 500 cashback on payments above Rs. 999 with Mobikwik Wallet
APLAZYPAYUpto Rs. 300 cashback on 1st transaction of Rs. 500 and above with LazyPay
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Composition :
DAPAGLIFLOZIN-10MG
Manufacturer/Marketer :
TABQ THERAPEUTICS
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
Severe
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Novaglif-10 Tablet:
Co-administration of Novaglif-10 Tablet with Gatifloxacin may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Gatifloxacin can be taken with Novaglif-10 Tablet if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue the medication without consulting a doctor.
Co-administration of Novaglif-10 Tablet with Gatifloxacin may sometimes affect blood glucose levels. Both low blood glucose and, less frequently, high blood glucose have been reported.
How to manage the interaction:
Although there is a possible interaction, Gatifloxacin can be taken with Novaglif-10 Tablet if prescribed by the doctor. Consult the prescriber if you experience symptoms such as nervousness, confusion, headache, dizziness, drowsiness, tremor, nausea, hunger, weakness, perspiration, palpitation, rapid heartbeat, increased urination, increased thirst, and increased hunger. Maintaining blood glucose levels is advised. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Novaglif-10 Tablet:
Co-administration of Novaglif-10 Tablet with Aliskiren may increase the risk of dehydration and low blood pressure.
How to manage the interaction:
If you are supposed to use Novaglif-10 Tablet and Aliskiren together, a doctor may adjust the dose and monitor you more frequently. However, if you experience dizziness, fainting, headache, lightheadedness, and/or changes in pulse or heart rate, contact a doctor. Do not discontinue the medication without consulting a doctor.
Co-administration of Novaglif-10 Tablet with Aliskiren may increase the risk of dehydration and low blood pressure.
How to manage the interaction:
If you are supposed to use Novaglif-10 Tablet and Aliskiren together, a doctor may adjust the dose and monitor you more frequently. However, if you experience dizziness, fainting, headache, lightheadedness, and/or changes in pulse or heart rate, contact a doctor. Do not discontinue the medication without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
Prescription drugWhats That
coupon
Drug-Diseases Interactions
DAPAGLIFLOZIN-10MGHepatic failure, not elsewhere classified
Severe
DAPAGLIFLOZIN-10MGAcute renal failure
Severe
Drug-Diseases Interactions
Login/Sign Up
DAPAGLIFLOZIN-10MGHepatic failure, not elsewhere classified
Severe
How does the disease interact with Novaglif-10 Tablet:
Use caution when using Novaglif-10 Tablet in individuals with severe hepatic impairment. Patients with mild or moderate hepatic impairment do not require dosage modifications.
How to manage the interaction:
Novaglif-10 Tablet should be used with caution in patients with liver impairment.
Use caution when using Novaglif-10 Tablet in individuals with severe hepatic impairment. Patients with mild or moderate hepatic impairment do not require dosage modifications.
How to manage the interaction:
Novaglif-10 Tablet should be used with caution in patients with liver impairment.
DAPAGLIFLOZIN-10MGAcute renal failure
Severe
How does the disease interact with Novaglif-10 Tablet:
In patients with deteriorating renal function, the glucose-lowering effects of SGLT2 inhibitors are reduced. Acute kidney damage and hypotension are side effects with volume depletion are common in patients with renal impaired function, the elderly, and those using loop diuretics. It is not recommended to use SGLT-2 inhibitors in dialysis patients.
How to manage the interaction:
Novaglif-10 Tablet is contraindicated in patients undergoing dialysis.
In patients with deteriorating renal function, the glucose-lowering effects of SGLT2 inhibitors are reduced. Acute kidney damage and hypotension are side effects with volume depletion are common in patients with renal impaired function, the elderly, and those using loop diuretics. It is not recommended to use SGLT-2 inhibitors in dialysis patients.
How to manage the interaction:
Novaglif-10 Tablet is contraindicated in patients undergoing dialysis.
DAPAGLIFLOZIN-10MGHypotension
Moderate
How does the disease interact with Novaglif-10 Tablet:
After the start of treatment, SGLT-2 inhibitors promote intravascular volume contraction, which may result in symptomatic hypotension, particularly in the elderly, in patients with impaired renal function, in patients with low systolic blood pressure, or in patients using diuretics. Monitor volume status.
How to manage the interaction:
Blood plasma volume should be assessed and corrected before starting treatment with Novaglif-10 Tablet, and patients should be monitored during therapy.
After the start of treatment, SGLT-2 inhibitors promote intravascular volume contraction, which may result in symptomatic hypotension, particularly in the elderly, in patients with impaired renal function, in patients with low systolic blood pressure, or in patients using diuretics. Monitor volume status.
How to manage the interaction:
Blood plasma volume should be assessed and corrected before starting treatment with Novaglif-10 Tablet, and patients should be monitored during therapy.
DAPAGLIFLOZIN-10MGUnspecified mycosis
Moderate
How does the disease interact with Novaglif-10 Tablet:
The use of sodium-glucose cotransporter 2 inhibitors may cause increased risk of genital mycotic infections. When administering this medication to patients who have a history of genital mycotic infections, caution should be taken. Monitor closely.
How to manage the interaction:
Novaglif-10 Tablet should be used with caution in patients who have a history of genital mycotic infections (fungal infections of the urogenital area) or who are uncircumcised, as these patients are more likely to develop genital mycotic infections.
The use of sodium-glucose cotransporter 2 inhibitors may cause increased risk of genital mycotic infections. When administering this medication to patients who have a history of genital mycotic infections, caution should be taken. Monitor closely.
How to manage the interaction:
Novaglif-10 Tablet should be used with caution in patients who have a history of genital mycotic infections (fungal infections of the urogenital area) or who are uncircumcised, as these patients are more likely to develop genital mycotic infections.
Have a query?
Customers Also Bought
